161 related articles for article (PubMed ID: 23268661)
1. The impact of drug shortages on children with cancer--the example of mechlorethamine.
Metzger ML; Billett A; Link MP
N Engl J Med; 2012 Dec; 367(26):2461-3. PubMed ID: 23268661
[No Abstract] [Full Text] [Related]
2. Treatment of pediatric Hodgkin disease avoiding radiotherapy: excellent outcome with the Rotterdam-HD-84-protocol.
Hakvoort-Cammel FG; Buitendijk S; van den Heuvel-Eibrink M; Hählen K
Pediatr Blood Cancer; 2004 Jul; 43(1):8-16. PubMed ID: 15170884
[TBL] [Abstract][Full Text] [Related]
3. [Drug therapy of Hodgkin's disease].
Gallmeier WM; Bruntsch U
Internist (Berl); 1981 May; 22(5):289-300. PubMed ID: 7019138
[No Abstract] [Full Text] [Related]
4. Medicine. Shortages of cancer drugs put patients, trials at risk.
Kaiser J
Science; 2011 Apr; 332(6029):523. PubMed ID: 21527686
[No Abstract] [Full Text] [Related]
5. Drug shortages--a critical challenge for the generic-drug market.
Chabner BA
N Engl J Med; 2011 Dec; 365(23):2147-9. PubMed ID: 22040167
[No Abstract] [Full Text] [Related]
6. Chemotherapy and Supportive Care Agents as Essential Medicines for Children With Cancer.
Unguru Y; Bernhardt MB; Berg SL; Johnson LM; Pyke-Grimm K; Woodman C; Fernandez CV
JAMA Pediatr; 2019 May; 173(5):477-484. PubMed ID: 30830204
[TBL] [Abstract][Full Text] [Related]
7. [Use of risk-adapted programs of treatment of Hodgkin's disease in children and adolescents].
Kuleva SA
Vopr Onkol; 2008; 54(6):768-70. PubMed ID: 19241857
[TBL] [Abstract][Full Text] [Related]
8. [Chemotherapy of Hodgkin disease with modified MOPP].
Amiel JL; Spielmann M; Kerbrat P; Droz JP; Tursz T; Ben Ayed F
Schweiz Rundsch Med Prax; 1983 Feb; 72(6):190-3. PubMed ID: 6687638
[No Abstract] [Full Text] [Related]
9. Are ABVD and MOPP/ABV truly equivalent for treating Hodgkin's disease at advanced stages?
Andrieu JM; Colonna P
J Clin Oncol; 1998 Jun; 16(6):2283. PubMed ID: 9626234
[No Abstract] [Full Text] [Related]
10. The shortage of essential chemotherapy drugs in the United States.
Gatesman ML; Smith TJ
N Engl J Med; 2011 Nov; 365(18):1653-5. PubMed ID: 22040130
[No Abstract] [Full Text] [Related]
11. [Successful chemotherapy of cancer. Remission of Hodgkin's disease. IV].
Lopez M
Clin Ter; 2001; 152(3):203-6. PubMed ID: 11692542
[No Abstract] [Full Text] [Related]
12. Drug shortages delay cancer clinical trials.
Goozner M
J Natl Cancer Inst; 2012 Jun; 104(12):891-2. PubMed ID: 22715189
[No Abstract] [Full Text] [Related]
13. [Hodgkin's disease: treatment of clinical stages II3+A, IB, IIB, IIIA and IIIB with short chemotherapy (3 MOPP, or 3 CVPP), splenectomy and limited irradiation. Results after 4 years of a prospective protocol including 94 patients].
Andrieu JM; Casassus P; Coscas Y; Darmont J; Goubeau C; Katz M; Jacquillat C; Tricot G; Weil M
Bull Cancer; 1982; 69(4):321-9. PubMed ID: 6897520
[No Abstract] [Full Text] [Related]
14. [Drug therapy of malignant lymphoma].
Ogawa M; Inagaki J
Rinsho Hoshasen; 1985 Oct; 30(11):1317-32. PubMed ID: 2418229
[No Abstract] [Full Text] [Related]
15. Framework for tackling paediatric chemotherapy drug shortages.
Tanday S
Lancet Oncol; 2016 Mar; 17(3):e93. PubMed ID: 26831287
[No Abstract] [Full Text] [Related]
16. [Hodgkin's disease in children; treatment results with or without radiotherapy].
Behrendt H
Ned Tijdschr Geneeskd; 1986 May; 130(19):865-8. PubMed ID: 3754935
[No Abstract] [Full Text] [Related]
17. Combined modality therapy in previously untreated patients with advanced Hodgkin's disease: A 24-year follow-up study.
Salloum E; Doria R; Farber LR; Roberts KB; Cooper DL
Cancer J Sci Am; 1995; 1(4):267-73. PubMed ID: 9166487
[TBL] [Abstract][Full Text] [Related]
18. Current status and new vistas in combination chemotherapy.
Frei E
Mt Sinai J Med; 1985 Jun; 52(6):460-4. PubMed ID: 3875026
[No Abstract] [Full Text] [Related]
19. [Peculiarities of the recurrence of lymphogranulomatosis in children following combined chemotherapy].
Kolygin BA; Kharatishvili ZV
Vopr Onkol; 1983; 29(8):12-5. PubMed ID: 6688487
[TBL] [Abstract][Full Text] [Related]
20. [Chemotherapy of Hodgkin disease].
Gallmeier WM; Bruntsch U
MMW Munch Med Wochenschr; 1982 Sep; 124(37):800-3. PubMed ID: 6813724
[No Abstract] [Full Text] [Related]
[Next] [New Search]